Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy. | Front Pharmacol | 2023 | 38074139 | PubTator, text mining | PubMed |
| MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches? | Cancers (Basel) | 2023 | 38067261 | PubTator, text mining | PubMed |
| A pan-cancer analysis of TNFAIP8L1 in human tumors. | Medicine (Baltimore) | 2023 | 38065896 | PubTator, text mining | PubMed |
| KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN. | Heliyon | 2023 | 38058614 | PubTator, text mining | PubMed |
| A unique binding pocket induced by a noncanonical SAH mimic to develop potent and selective PRMT inhibitors. | Acta Pharm Sin B | 2023 | 38045046 | PubTator, text mining | PubMed |
| Aortic aneurysms: current pathogenesis and therapeutic targets. | Exp Mol Med | 2023 | 38036736 | PubTator, text mining | PubMed |
| Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma. | Front Immunol | 2023 | 38035085 | PubTator, text mining | PubMed |
| Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance. | Cancer Res Commun | 2023 | 38014922 | PubTator, text mining | PubMed |
| PRMT1 orchestrates with SAMTOR to govern mTORC1 methionine sensing via Arg-methylation of NPRL2. | Cell Metab | 2023 | 38006878 | Swiss-Prot, curated | PubMed |
| Structural and pKa Estimation of the Amphipathic HR1 in SARS-CoV-2: Insights from Constant pH MD, Linear vs. Nonlinear Normal Mode Analysis. | Int J Mol Sci | 2023 | 38003380 | PubTator, text mining | PubMed |
| Advances and Perspectives in Relation to the Molecular Basis of Diabetic Retinopathy-A Review. | Biomedicines | 2023 | 38001952 | PubTator, text mining | PubMed |
| The Contribution of Hippocampal All-Trans Retinoic Acid (ATRA) Deficiency to Alzheimer's Disease: A Narrative Overview of ATRA-Dependent Gene Expression in Post-Mortem Hippocampal Tissue. | Antioxidants (Basel) | 2023 | 38001775 | PubTator, text mining | PubMed |
| Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further Enhance Anticancer Drug Development. | Curr Issues Mol Biol | 2023 | 37998757 | PubTator, text mining | PubMed |
| Machine Learning Analysis of Alzheimer's Disease Single-Cell RNA-Sequencing Data across Cortex and Hippocampus Regions. | Curr Issues Mol Biol | 2023 | 37998721 | PubTator, text mining | PubMed |
| CDK5: an oncogene or an anti-oncogene: location location location. | Mol Cancer | 2023 | 37993880 | PubTator, text mining | PubMed |
| PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma. | Adv Sci (Weinh) | 2023 | 37973560 | PubTator, text mining | PubMed |
| Nucleolar reorganization after cellular stress is orchestrated by SMN shuttling between nuclear compartments. | Nat Commun | 2023 | 37968267 | PubTator, text mining | PubMed |
| Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target. | Cancers (Basel) | 2023 | 37958417 | PubTator, text mining | PubMed |
| UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis. | Cell Death Dis | 2023 | 37957138 | PubTator, text mining | PubMed |
| Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers. | Breast Cancer (Dove Med Press) | 2023 | 37954171 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=14